Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 08:00 ET | Source: Medidata Solutions, Inc.

Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and CTI Clinical Trial and Consulting...
November 04, 2025 07:00 ET | Source: Tilray Brands, Inc.

Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada

LEAMINGTON, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the...
November 04, 2025 07:00 ET | Source: National Community Pharmacists Association

NCPA and USC Launch First Publicly Available Tool to Identify Pharmacy Shortage Areas Across America

Alexandria, Va., Nov. 04, 2025 (GLOBE NEWSWIRE) -- The National Community Pharmacists Association (NCPA), in collaboration with the University of Southern California (USC), today unveiled an...
October 30, 2025 12:00 ET | Source: Medidata Solutions, Inc.

Medidata Unveils Next-Generation Patient Consent Innovations, Designed in Partnership with Clinicians and Patient Advocates

Medidata Consent, a key part of the Medidata Patient Experience, expedites study start-up, reduces configuration complexity, and improves patient enrollment NEW YORK, Oct. 30, 2025 (GLOBE...
October 30, 2025 06:00 ET | Source: Oncotelic Therapeutics, Inc.

Sapu Nano to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle™ Everolimus)

AGOURA HILLS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create, test, and deliver transformative...
September 17, 2025 14:43 ET | Source: Forte Medical Limited

Are Women on the Frontline of Antimicrobial Resistance?

Are women on the AMR Frontline? Results of a national patient survey of women's experiences around Urinary Tract Infection and antibiotic prescribing
September 17, 2025 02:00 ET | Source: Opterion Health AG

Opterion Health AG submits Clinical Trial Application for First-in-Human Study of OPT101 in Patients with Advanced Chronic Kidney Disease

MUTTENZ, Switzerland, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company developing OPT101 as an innovative treatment for patients on peritoneal...
July 24, 2025 07:00 ET | Source: MediPharm Labs Corp.

MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler

MediPharm Labs Launches New Shake & Puff CBN THC Nighttime Metered Dose Inhaler in Canada.
July 23, 2025 20:00 ET | Source: Palisade Bio, Inc.

Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million

Carlsbad, CA, July 23, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing...
July 17, 2025 21:16 ET | Source: Sapu Biosciences, LLC

SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients

Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif., July 17, 2025 (GLOBE...